Published in Epilepsia on March 01, 1989
Psychoanatomical substrates of Bálint's syndrome. J Neurol Neurosurg Psychiatry (2002) 1.11
Cortical blindness with absent visually evoked potential in non-ketotic hyperglycemia. Indian J Ophthalmol (2007) 0.76
Performance of a seizure warning algorithm based on the dynamics of intracranial EEG. Epilepsy Res (2005) 3.02
An active-control trial of lamotrigine monotherapy for partial seizures. Neurology (1998) 2.24
Preferential neuronal loss in layer III of the entorhinal cortex in patients with temporal lobe epilepsy. Epilepsy Res (1993) 1.67
Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial. Neurology (2000) 1.65
Phase space topography and the Lyapunov exponent of electrocorticograms in partial seizures. Brain Topogr (1990) 1.52
Cortical blindness: etiology, diagnosis, and prognosis. Ann Neurol (1987) 1.51
Generalized absence seizures with 10-15 Hz fast discharges. Clin Neurophysiol (1999) 1.46
Intraventricular monitoring for temporal lobe epilepsy: report on technique and initial results in eight patients. J Neurol Neurosurg Psychiatry (2003) 1.41
MRI asymmetries and language dominance. Neurology (1994) 1.41
Brief antiepileptic drug withdrawal prolongs interval to next seizure. Neurology (1999) 1.38
Long-term prospective on-line real-time seizure prediction. Clin Neurophysiol (2005) 1.33
Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures. Neurology (2005) 1.28
Neurological abnormalities associated with remote occupational elemental mercury exposure. Ann Neurol (1988) 1.21
Shoulder enlargement as the presenting sign in syringomyelia. Report of two cases and review of the literature. JAMA (1976) 1.20
The course of seizure disorders in patients with malignant gliomas. Arch Neurol (1995) 1.18
Patients with partial seizures: evaluation by MR, CT, and PET imaging. Radiology (1986) 1.12
Acute sensory neuropathy-neuronopathy from pyridoxine overdose. Neurology (1987) 1.10
Visual field defects after temporal lobe resection: a prospective quantitative analysis. Neurology (1999) 1.10
Time dependencies in the occurrences of epileptic seizures. Epilepsy Res (1994) 1.05
Adult myoclonic epilepsy: a distinct syndrome of idiopathic generalized epilepsy. Neurology (2000) 1.04
Valproic acid versus ethosuximide in the treatment of absence seizures. Neurology (1982) 1.04
Academic achievement of children with epilepsy. Epilepsia (1987) 1.04
Epilepsy diagnosis and localization in patients with antecedent childhood febrile convulsions. Neurology (1998) 1.04
Self-injury and incontinence in psychogenic seizures. Epilepsia (1995) 0.99
Altered excitatory and inhibitory amino acid receptor binding in hippocampus of patients with temporal lobe epilepsy. Ann Neurol (1991) 0.99
Recombinant human tissue-type plasminogen activator therapy in acute thromboembolic stroke. J Neurosurg (1987) 0.97
Intensive monitoring in refractory epilepsy. Neurology (1981) 0.97
Measuring the coherence of intracranial electroencephalograms. Clin Neurophysiol (1999) 0.96
Evaluation of childhood pseudoseizures using EEG telemetry and video tape monitoring. J Pediatr (1980) 0.95
Assessment of a scalp EEG-based automated seizure detection system. Clin Neurophysiol (2010) 0.95
Stupor following administration of valproic acid to patients receiving other antiepileptic drugs. Epilepsia (1979) 0.94
EEG changes in intrathecal baclofen overdose: a case report and review of the literature. Electroencephalogr Clin Neurophysiol (1998) 0.93
Clinical variability in adult-onset acid maltase deficiency: report of affected sibs and review of the literature. Medicine (Baltimore) (1995) 0.92
Gabapentin: pharmacokinetics, efficacy, and safety. Clin Neuropharmacol (1995) 0.92
Non-linearity in invasive EEG recordings from patients with temporal lobe epilepsy. Electroencephalogr Clin Neurophysiol (1997) 0.91
Efficacy and safety of zonisamide: results of a multicenter study. Epilepsy Res (1993) 0.91
Safety and efficacy of divalproex sodium monotherapy in partial epilepsy: a double-blind, concentration-response design clinical trial. Depakote Monotherapy for Partial Seizures Study Group. Neurology (1997) 0.91
Personality of patients with pseudoseizures. Neurology (1986) 0.91
In vivo cerebral metabolism and central benzodiazepine-receptor binding in temporal lobe epilepsy. Neurology (1993) 0.90
Modelling of ECoG in temporal lobe epilepsy. Biomed Sci Instrum (1988) 0.90
Low-dose stereotactic radiosurgery is inadequate for medically intractable mesial temporal lobe epilepsy: a case report. Seizure (2001) 0.89
Aphasia secondary to partial status epilepticus of the basal temporal language area. Neurology (1995) 0.88
Midsagittal corpus callosum area, intelligence, and language dominance in epilepsy. J Neuroimaging (1996) 0.87
Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study Group. Neurology (2000) 0.86
Intellectual and neuropsychological features of patients with psychogenic pseudoseizures. Psychiatry Res (1999) 0.86
Familial mesial temporal lobe epilepsy maps to chromosome 4q13.2-q21.3. Neurology (2007) 0.86
Pilot study of zonisamide (1,2-benzisoxazole-3-methanesulfonamide) in patients with refractory partial seizures. Epilepsia (1985) 0.86
Time-frequency representation of electrocorticograms in temporal lobe epilepsy. IEEE Trans Biomed Eng (1992) 0.86
Positron emission tomography studies of cerebral glucose metabolism in chronic partial epilepsy. Ann Neurol (1987) 0.85
Zonisamide (CI-912) and cognition: results from preliminary study. Epilepsia (1987) 0.85
Temporal lobe central benzodiazepine binding in unilateral mesial temporal lobe epilepsy. Neurology (1995) 0.85
Intelligence test performance of patients with partial and generalized seizures. Epilepsia (1985) 0.85
The effect of diazepam sedation on cerebral glucose metabolism in Alzheimer's disease as measured using positron emission tomography. J Cereb Blood Flow Metab (1987) 0.84
Antidepressant withdrawal syndromes: evidence supporting the cholinergic overdrive hypothesis. J Clin Psychopharmacol (1983) 0.84
Predictability of epileptic seizures: a comparative study using Lyapunov exponent and entropy based measures. Biomed Sci Instrum (2003) 0.82
Felbamate: a double-blind controlled trial in patients undergoing presurgical evaluation of partial seizures. Neurology (1993) 0.82
Statistically driven identification of focal metabolic abnormalities in temporal lobe epilepsy with corrections for tissue heterogeneity using 1H spectroscopic imaging. Magn Reson Med (2000) 0.81
Analysis of MMPI patterns in patients with psychogenic pseudoseizures. Seizure (1997) 0.81
Differential effects of isoflurane on human median nerve somatosensory evoked potentials. Anesthesiology (1987) 0.81
Psychogenic seizures in old age: a case report. Epilepsia (1994) 0.81
Status epilepticus and tiagabine therapy: review of safety data and epidemiologic comparisons. Epilepsia (2001) 0.81
Personality profiles of patients with pseudoseizures. Seizure (1997) 0.81
Effects of age of onset of partial and generalized seizures on neuropsychological performance in children. J Nerv Ment Dis (1983) 0.81
Video-EEG in the diagnosis of paroxysmal events in children with mental retardation and in children with normal intelligence. Dev Med Child Neurol (2001) 0.80
The value of combined ambulatory cassette-EEG and video monitoring in the differential diagnosis of intractable seizures. Clin Neurophysiol (1999) 0.80
Impaired motor function in patients with psychogenic pseudoseizures. Epilepsia (2001) 0.80
ABSENCE SEIZURES AS RESETTING MECHANISMS OF BRAIN DYNAMICS. Cybern Syst Anal (2008) 0.80
Differentiating clinical features of right and left temporal lobe seizures. Epilepsia (1994) 0.79
The generalized tonic-clonic seizure in partial versus generalized epilepsy: semiologic differences. Epilepsia (1999) 0.79
Muscarinic receptor loss and preservation of presynaptic cholinergic terminals in hippocampal sclerosis. Epilepsia (1999) 0.79
Absence seizures with evolution into generalized tonic-clonic activity: clinical and EEG features. Epilepsia (2000) 0.79
Pre-operative extracranial and intracranial EEG investigation in patients with temporal lobe epilepsy: trends, results and review of pathophysiologic mechanisms. Acta Neurol Scand Suppl (1988) 0.79
Evidence for familial association of psychiatric disorders and epilepsy. Biol Psychiatry (1994) 0.78
Limbic encephalitis and hyperactive foci on PET scan. Seizure (1999) 0.78
Topiramate titration and tolerability. Ann Pharmacother (2001) 0.78
Conversion to high dose gabapentin monotherapy in patients with medically refractory partial epilepsy. Epilepsia (1998) 0.78
Hashimoto's encephalopathy: documentation of mesial temporal seizure origin by ictal EEG. Seizure (2001) 0.78
Safety of long-term treatment with tiagabine. Seizure (2000) 0.78
Patients with pseudoseizures: intellectual and cognitive performance. Neurology (1985) 0.77
Association of ipsilateral head turning and dystonia in temporal lobe seizures. Epilepsia (1995) 0.77
Flunarizine for treatment of partial seizures: results of a concentration-controlled trial. Neurology (1994) 0.77
Stepwise determination of multicompartment disposition and absorption parameters from extravascular concentration-time data. Application to mesoridazine, flurbiprofen, flunarizine, labetalol, and diazepam. J Pharmacokinet Biopharm (1991) 0.77
Felbamate pharmacology and use in epilepsy. Clin Neuropharmacol (1994) 0.77
Evidence for the presynaptic localization of opiate binding sites on striatal efferent fibers. Brain Res (1984) 0.77
The start-stop-start phenomenon in scalp-sphenoidal ictal recordings. Electroencephalogr Clin Neurophysiol (1996) 0.76
Multimodality evoked potential testing in acute mild closed head injury. Arch Phys Med Rehabil (1991) 0.76
Orbito-frontal epilepsy masquerading as temporal lobe epilepsy-a case report. Seizure (2001) 0.76
Right hemisphere partial complex seizures: mania, hallucinations, and speech disturbances during ictal events. Epilepsia (1988) 0.76
Myoclonus with electrocerebral silence in a patient receiving penicillin. Arch Neurol (1979) 0.75
Correlation of evoked potential and MRI findings in Wilson's disease. Neurology (1993) 0.75
Reduction of steady-state valproate levels by other antiepileptic drugs. Epilepsia (1981) 0.75